Adrian J. Park

Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects

Katie Wynne, Adrian J. Park, Caroline J. Small et al. · Diabetes · 2005 · 429 citations · Full text

Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively

Nicola M. Neary, Caroline J. Small, Maralyn Druce et al. · Endocrinology · 2005 · 370 citations

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

C. L. Dakin, Caroline J. Small, Adrian J. Park et al. · American Journal of Physiology-Endocrinology and Metabolism · 2002 · 143 citations

Low-dose pancreatic polypeptide inhibits food intake in man

David Jesudason, Mariana P. Monteiro, Barbara McGowan et al. · British Journal Of Nutrition · 2007 · 84 citations · Full text

Obesity, Metabolic Syndrome, Nutrition +15

Can encapsulated glutamine increase GLP-1 secretion, improve glucose tolerance, and reduce meal size in healthy volunteers? A randomised, placebo-controlled, cross-over trial

Claire L. Meek, Frank Reimann, Adrian J. Park et al. · The Lancet · 2015 · 15 citations · Full text

Nutrition, Glucose Tolerance, Diabetes Management +6